Literature DB >> 27019343

Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations.

Alberto Cuzzolin1, Mattia Sturlese1, Giuseppe Deganutti1, Veronica Salmaso1, Davide Sabbadin1, Antonella Ciancetta1, Stefano Moro1.   

Abstract

Molecular recognition is a crucial issue when aiming to interpret the mechanism of known active substances as well as to develop novel active candidates. Unfortunately, simulating the binding process is still a challenging task because it requires classical MD experiments in a long microsecond time scale that are affordable only with a high-level computational capacity. In order to overcome this limiting factor, we have recently implemented an alternative MD approach, named supervised molecular dynamics (SuMD), and successfully applied it to G protein-coupled receptors (GPCRs). SuMD enables the investigation of ligand-receptor binding events independently from the starting position, chemical structure of the ligand, and also from its receptor binding affinity. In this article, we present an extension of the SuMD application domain including different types of proteins in comparison with GPCRs. In particular, we have deeply analyzed the ligand-protein recognition pathways of six different case studies that we grouped into two different classes: globular and membrane proteins. Moreover, we introduce the SuMD-Analyzer tool that we have specifically implemented to help the user in the analysis of the SuMD trajectories. Finally, we emphasize the limit of the SuMD applicability domain as well as its strengths in analyzing the complexity of ligand-protein recognition pathways.

Mesh:

Substances:

Year:  2016        PMID: 27019343     DOI: 10.1021/acs.jcim.5b00702

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  24 in total

1.  Coupling Supervised Molecular Dynamics (SuMD) with Entropy Estimations To Shine Light on the Stability of Multiple Binding Sites.

Authors:  Shailesh Kumar Panday; Mattia Sturlese; Veronica Salmaso; Indira Ghosh; Stefano Moro
Journal:  ACS Med Chem Lett       Date:  2019-02-15       Impact factor: 4.345

Review 2.  An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.

Authors:  Ugo Perricone; Maria Rita Gulotta; Jessica Lombino; Barbara Parrino; Stella Cascioferro; Patrizia Diana; Girolamo Cirrincione; Alessandro Padova
Journal:  Medchemcomm       Date:  2018-04-19       Impact factor: 3.597

3.  Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics.

Authors:  Giuseppe Deganutti; Andrei Zhukov; Francesca Deflorian; Stephanie Federico; Giampiero Spalluto; Robert M Cooke; Stefano Moro; Jonathan S Mason; Andrea Bortolato
Journal:  In Silico Pharmacol       Date:  2017-11-20

4.  Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example.

Authors:  Stephanie Federico; Enrico Margiotta; Silvia Paoletta; Sonja Kachler; Karl-Norbert Klotz; Kenneth A Jacobson; Giorgia Pastorin; Stefano Moro; Giampiero Spalluto
Journal:  Medchemcomm       Date:  2019-02-18       Impact factor: 3.597

5.  The full activation mechanism of the adenosine A1 receptor revealed by GaMD and Su-GaMD simulations.

Authors:  Yang Li; Jixue Sun; Dongmei Li; Jianping Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

6.  Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression.

Authors:  Mark J Wall; Emily Hill; Robert Huckstepp; Kerry Barkan; Giuseppe Deganutti; Michele Leuenberger; Barbara Preti; Ian Winfield; Sabrina Carvalho; Anna Suchankova; Haifeng Wei; Dewi Safitri; Xianglin Huang; Wendy Imlach; Circe La Mache; Eve Dean; Cherise Hume; Stephanie Hayward; Jess Oliver; Fei-Yue Zhao; David Spanswick; Christopher A Reynolds; Martin Lochner; Graham Ladds; Bruno G Frenguelli
Journal:  Nat Commun       Date:  2022-07-18       Impact factor: 17.694

7.  Conjugable A3 adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes.

Authors:  Stephanie Federico; Enrico Margiotta; Stefano Moro; Eszter Kozma; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Eur J Med Chem       Date:  2019-11-22       Impact factor: 6.514

8.  Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.

Authors:  Rebekah L Bower; Lauren Yule; Tayla A Rees; Giuseppe Deganutti; Erica R Hendrikse; Paul W R Harris; Renata Kowalczyk; Zachary Ridgway; Amy G Wong; Katarzyna Swierkula; Daniel P Raleigh; Augen A Pioszak; Margaret A Brimble; Christopher A Reynolds; Christopher S Walker; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2018-04-23

9.  Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 Mpro by Using Supervised Molecular Dynamics (SuMD) Simulations.

Authors:  Maicol Bissaro; Giovanni Bolcato; Matteo Pavan; Davide Bassani; Mattia Sturlese; Stefano Moro
Journal:  ChemMedChem       Date:  2021-05-06       Impact factor: 3.540

10.  Deciphering the Agonist Binding Mechanism to the Adenosine A1 Receptor.

Authors:  Giuseppe Deganutti; Kerry Barkan; Barbara Preti; Michele Leuenberger; Mark Wall; Bruno G Frenguelli; Martin Lochner; Graham Ladds; Christopher A Reynolds
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.